Anna Lissina

1.5k total citations
17 papers, 740 citations indexed

About

Anna Lissina is a scholar working on Immunology, Virology and Oncology. According to data from OpenAlex, Anna Lissina has authored 17 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 4 papers in Virology and 3 papers in Oncology. Recurrent topics in Anna Lissina's work include Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (13 papers) and Immunotherapy and Immune Responses (10 papers). Anna Lissina is often cited by papers focused on Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (13 papers) and Immunotherapy and Immune Responses (10 papers). Anna Lissina collaborates with scholars based in United Kingdom, United States and France. Anna Lissina's co-authors include David A. Price, Linda Wooldridge, Andrew K. Sewell, Hugo A. van den Berg, Emma Gostick, David K. Cole, Victor Appay, Vincenzo Cerundolo, P. Rod Dunbar and Fareed Mirza and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Scientific Reports.

In The Last Decade

Anna Lissina

17 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Lissina United Kingdom 14 622 178 144 98 61 17 740
Roybel R. Ramiscal Australia 7 972 1.6× 117 0.7× 188 1.3× 87 0.9× 53 0.9× 7 1.2k
Silvia Preite United States 12 618 1.0× 124 0.7× 140 1.0× 166 1.7× 70 1.1× 13 853
Frieder Koszik Austria 14 574 0.9× 207 1.2× 136 0.9× 51 0.5× 41 0.7× 22 734
Hyun Tak Jin South Korea 8 446 0.7× 281 1.6× 102 0.7× 113 1.2× 48 0.8× 10 621
Leigh A. O’Mara United States 10 715 1.1× 227 1.3× 137 1.0× 174 1.8× 66 1.1× 12 916
Kristian Hallermalm Sweden 12 274 0.4× 141 0.8× 228 1.6× 65 0.7× 40 0.7× 18 504
Peter Manders Australia 12 601 1.0× 222 1.2× 146 1.0× 126 1.3× 49 0.8× 16 922
Béatrice Corre France 13 340 0.5× 252 1.4× 174 1.2× 53 0.5× 50 0.8× 21 603
Katherine Bourne Australia 11 707 1.1× 89 0.5× 145 1.0× 54 0.6× 66 1.1× 11 855
Flavia E. Popescu United States 8 536 0.9× 201 1.1× 173 1.2× 55 0.6× 51 0.8× 10 773

Countries citing papers authored by Anna Lissina

Since Specialization
Citations

This map shows the geographic impact of Anna Lissina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lissina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lissina more than expected).

Fields of papers citing papers by Anna Lissina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lissina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lissina. The network helps show where Anna Lissina may publish in the future.

Co-authorship network of co-authors of Anna Lissina

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lissina. A scholar is included among the top collaborators of Anna Lissina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lissina. Anna Lissina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Papagno, Laura, Nozomi Kuse, Anna Lissina, et al.. (2020). The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8+ T-cell responses in vitro. Scientific Reports. 10(1). 11620–11620. 13 indexed citations
2.
Kuse, Nozomi, Xiaoming Sun, Tomohiro Akahoshi, et al.. (2019). Priming of HIV-1-specific CD8+ T cells with strong functional properties from naïve T cells. EBioMedicine. 42. 109–119. 15 indexed citations
3.
Lissina, Anna, James E. McLaren, Mette Ilander, et al.. (2018). Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8+ TCR-Vβ+ expansions. Scientific Reports. 8(1). 2534–2534. 2 indexed citations
4.
Lissina, Anna, Lisa A. Chakrabarti, Masafumi Takiguchi, & Victor Appay. (2016). TCR clonotypes: molecular determinants of T-cell efficacy against HIV. Current Opinion in Virology. 16. 77–85. 14 indexed citations
5.
Lissina, Anna, David R. Ambrozak, Kristin L. Boswell, et al.. (2016). Fine‐tuning of CD8+ T‐cell effector functions by targeting the 2B4‐CD48 interaction. Immunology and Cell Biology. 94(6). 583–592. 11 indexed citations
6.
Briceño, Olivia, Anna Lissina, Kerstin Wanke, et al.. (2015). Reduced naïve CD 8 + T ‐cell priming efficacy in elderly adults. Aging Cell. 15(1). 14–21. 107 indexed citations
7.
Lissina, Anna, Olivia Briceño, Georgia Afonso, et al.. (2015). Priming of Qualitatively Superior Human Effector CD8+ T Cells Using TLR8 Ligand Combined with FLT3 Ligand. The Journal of Immunology. 196(1). 256–263. 29 indexed citations
8.
Lissina, Anna, Solène Fastenackels, Kristin Ladell, et al.. (2014). The link between CD8+ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate. AIDS. 28(4). 477–486. 8 indexed citations
9.
Makinde, Julia, Mathew Clement, David K. Cole, et al.. (2012). T-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen Targeting. Journal of Biological Chemistry. 287(44). 37269–37281. 37 indexed citations
10.
Wooldridge, Linda, Mathew Clement, Anna Lissina, et al.. (2010). MHC Class I Molecules with Superenhanced CD8 Binding Properties Bypass the Requirement for Cognate TCR Recognition and Nonspecifically Activate CTLs. The Journal of Immunology. 184(7). 3357–3366. 29 indexed citations
11.
Wooldridge, Linda, Anna Lissina, David K. Cole, et al.. (2009). Tricks with tetramers: how to get the most from multimeric peptide–MHC. Immunology. 126(2). 147–164. 132 indexed citations
12.
Lissina, Anna, Kristin Ladell, Ania Skowera, et al.. (2008). Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. Journal of Immunological Methods. 340(1). 11–24. 117 indexed citations
13.
Melenhorst, J. Joseph, Phillip Scheinberg, Pratip K. Chattopadhyay, et al.. (2008). Detection of low avidity CD8+ T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers. Journal of Immunological Methods. 338(1-2). 31–39. 30 indexed citations
14.
Gostick, Emma, David K. Cole, Sarah Hutchinson, et al.. (2007). Functional and biophysical characterization of an HLA‐A*6801‐restricted HIV‐specific T cell receptor. European Journal of Immunology. 37(2). 479–486. 20 indexed citations
15.
Wooldridge, Linda, Anna Lissina, Emma Gostick, et al.. (2007). Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. European Journal of Immunology. 37(5). 1323–1333. 55 indexed citations
16.
Choi, E, Ji‐Li Chen, Linda Wooldridge, et al.. (2003). High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining. The Journal of Immunology. 171(10). 5116–5123. 75 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roybel R. Ramiscal Breakdown of academic impact, for papers by Silvia Preite Breakdown of academic impact, for papers by Frieder Koszik Breakdown of academic impact, for papers by Hyun Tak Jin Breakdown of academic impact, for papers by Leigh A. O’Mara Breakdown of academic impact, for papers by Kristian Hallermalm Breakdown of academic impact, for papers by Peter Manders Breakdown of academic impact, for papers by Béatrice Corre Breakdown of academic impact, for papers by Katherine Bourne Breakdown of academic impact, for papers by Flavia E. Popescu
Rankless by CCL
2026